
Overview
Christina Annunziata is an Oncologist practicing medicine in Fairfax, Virginia.
Dr. Annunziata is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, and Testicular Yolk Sac Tumor.
She is actively involved in clinical research, co-authoring 110 peer reviewed articles and participating in 6 clinical trials. Dr. Annunziata is currently accepting new patients.
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- POS
- EPO
- HMO
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
8081 Innovation Park Dr, Level 6 - Potomac Clinic, Fairfax, VA 22031
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Virginia Cancer Specialists
Alexander Spira is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Spira is highly rated in 88 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Spira is currently accepting new patients.
Inova Schar Cancer Institute
Janakiraman Subramanian is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Subramanian is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Subramanian is currently accepting new patients.
Inova Schar Cancer Institute
Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon-Ching is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Prostate Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.
Mid Atlantic Gynecologic Oncology And Pelvic Surgery Associates
Leslie Randall is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Randall is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Hysterectomy. Dr. Randall is currently accepting new patients.
Mid Atlantic Gynecologic Oncology And Pelvic Surgery Associates
Annette Bicher is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Bicher is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Hernia Surgery, and Ureteroscopy. Dr. Bicher is currently accepting new patients.
Virginia Cancer Specialists
Dipti Patel is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Patel is highly rated in 80 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Patel is currently accepting new patients.
Frequently Asked Questions about Dr. Christina M. Annunziata
How do I make an appointment with Dr. Christina M. Annunziata?
You can book an appointment with Dr. Christina M. Annunziata by calling their office at 571-472-1660. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christina M. Annunziata a top-rated expert for Ovarian Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christina M. Annunziata is classified as an Elite expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christina M. Annunziata specialize in?
While Dr. Christina M. Annunziata is a Oncology, they have specific expertise in Ovarian Cancer, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Christina M. Annunziata participate in research or clinical trials?
Yes. Dr. Christina M. Annunziata has published 109 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Dr. Christina M. Annunziata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christina M. Annunziata accept my insurance?
Dr. Christina M. Annunziata accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 571-472-1660 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Ovarian CancerDr. Annunziata isElite. Learn about Ovarian Cancer.
- Advanced
- Endometrial CancerDr. Annunziata isAdvanced. Learn about Endometrial Cancer.
- Malignant Mixed Mullerian TumorDr. Annunziata isAdvanced. Learn about Malignant Mixed Mullerian Tumor.
- Ovarian CarcinosarcomaDr. Annunziata isAdvanced. Learn about Ovarian Carcinosarcoma.
- Sertoli-Leydig Cell TumorDr. Annunziata isAdvanced. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Annunziata isAdvanced. Learn about Testicular Yolk Sac Tumor.
- Triple-Negative Breast CancerDr. Annunziata isAdvanced. Learn about Triple-Negative Breast Cancer.
- Virilizing Ovarian TumorDr. Annunziata isAdvanced. Learn about Virilizing Ovarian Tumor.
- Experienced
- Adult Soft Tissue SarcomaDr. Annunziata isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Annunziata isExperienced. Learn about Agranulocytosis.
- Breast CancerDr. Annunziata isExperienced. Learn about Breast Cancer.
- Cervical CancerDr. Annunziata isExperienced. Learn about Cervical Cancer.
- Febrile NeutropeniaDr. Annunziata isExperienced. Learn about Febrile Neutropenia.
- FibrosarcomaDr. Annunziata isExperienced. Learn about Fibrosarcoma.
- Malignant Peripheral Nerve Sheath TumorDr. Annunziata isExperienced. Learn about Malignant Peripheral Nerve Sheath Tumor.
- Multiple MyelomaDr. Annunziata isExperienced. Learn about Multiple Myeloma.
- Pancreatic CancerDr. Annunziata isExperienced. Learn about Pancreatic Cancer.
- Pseudomyxoma PeritoneiDr. Annunziata isExperienced. Learn about Pseudomyxoma Peritonei.
- Vaginal CancerDr. Annunziata isExperienced. Learn about Vaginal Cancer.



